Home
About
FAQ
History (31)
Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study.
Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes.
End of Treatment Transition to Follow-Up Care among Early Stage Lung Cancer Survi
Collagen Type XIII
Is Left Ventricular Hypertrophy a Valid Therapeutic Target?
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is Left Ventricular Hypertrophy a Valid Therapeutic Target?
Brooks JE, Soliman EZ, Upadhya B. Is Left Ventricular Hypertrophy a Valid Therapeutic Target? Curr Hypertens Rep. 2019 05 20; 21(6):47.
View in:
PubMed
subject areas
Antihypertensive Agents
Humans
Hypertension
Hypertrophy, Left Ventricular
Risk Factors
authors with profiles
Elsayed Z. Soliman MD, MS